Deepbridge Capital LLP has seeded Acorn Partners Ltd, an efficient new way of originating, developing and delivering innovation within the broader healthcare space. In collaboration with our execution partners at WeAreNova and Europe’s largest children’s hospital Alder Hey, we redefine the... Read more
Incorporated in 2009 by Dr Kadem Al –Lamee and Mr Alastair Taylor, the Company commenced activities in November 2010 in the development of a novel next-generation polymer-based Bio-resorbable Coronary Scaffold (BRS), more commonly known as a ‘stent’. The bio-resorbable attribute allows the stent... Read more
Aurio Limited has developed a patentable core technology that potentially eases the debilitating effects of tinnitus.
Tinnitus is a perception of sound in the absence of an external source. Although it is often referred to as ‘ringing in the ears’, tinnitus can also be perceived as... Read more
BeamLine Diagnostics was set up to commercialise research in to the application of infrared spectroscopy to the diagnosis of cancer. Cancer is a worldwide problem with over 14 million new diagnoses and 8 million deaths recorded in 2012 alone (according to Cancer Research UK statistics, May 2015... Read more
Care Cube Solutions Ltd (‘CCSL’) is a networked digital workflow system designed by cardiologists for users to simplify and centralise the complex tracking of patient flow in cardiology departments. In doing so, the technology seeks to safeguard patients from human error, and also assists... Read more
Cell Lane Ltd has been established to develop a cell isolation and separation platform technology, based on intellectual property assigned from the University of Leeds. This new technology seeks to assist in the future treatment of chronic diseases such as cancer and AIDS, and is intended to... Read more
Elasmogen Ltd is a biologics company spun out of the University of Aberdeen in Feb 2016 and has developed a validated and IP-protected ‘soloMER’ platform. ‘soloMer’ refers to employ of small proteins as a site-specific drug delivery mechanism for ophthalmology and solid tumour cancers.
... Read more
EligoChem has developed a proprietary and patentable technology that facilitates the design of highly water-soluble drugs that are absorbed well by the human body. One in fifteen known drug compounds have this combination of properties, but they are present in only one in ten thousand... Read more
eLucid mHealth is a medication technology company creating proprietary, patented automatic adherence/compliance monitoring tools as part of an integrated healthcare system.
eLucid mHealth’s solutions and devices have been specifically designed with patient feedback; they are non-invasive... Read more
PEFA (‘paced electrogram fractionation analysis’) is a unique procedure and was invented by cardiologist Dr Richard Saumarez , initially when based at St Georges Hospital, London, and subsequently developed and tested at the University of Cambridge and Papworth Hospital.
The procedure that... Read more
Filisia addresses the training, rehabilitation and access requirements of people with special education and rehabilitation needs through creative and connected technology.
Filisia estimates that there are over 150 million people globally with... Read more
Glyconics Ltd is an innovative diagnostics company which has developed a novel approach to the diagnosis and monitoring of chronic and acute diseases including respiratory disease. The new device uses fourier transform infrared spectroscopy (FITR) to analyse sputum (saliva) samples for... Read more
Ibis Vision has developed ‘Ring of Sight’ (ROS), a unique eye test that is specifically designed for the early detection of glaucoma. Worldwide, glaucoma is the second most common cause of blindness and is caused by a build-up of pressure within the eye which in turn can damage the optic nerve... Read more
Inavya Ventures Ltd’s intention is to create a Machine Learning & Artificial Intelligence mobile application aimed primarily at improving interactions within the global healthcare, retail, hospitality and financial markets. The product and services offering is trademarked and called ‘AVATR... Read more
Keia Ltd was founded to address the very fragmented global market in which a large number of wellness practitioners operate. Wellness practitioners or holistic health practitioners are professionals who provide holistic health-related services, including counsellors, doctors, nurse... Read more
Levitex Foams Ltd was founded to address an identified need in the healthcare market for quality therapeutic mattresses. The company has developed a new Levitex foam product that directly addresses poor body alignment and posture, with a particular focus on those users that are bed-bound.... Read more
The Company was established in January 2015 by Professor Steven Ley at the University of Cambridge, following his observation that, due to industry developments such as the reduction in internal R&D spending and out-sourcing to low cost economies, access to the most creative and innovative... Read more
Nuchido Ltd was established to address the growing consumer demand for cosmeceutical products. Cosmeceuticals are the combination of cosmetics and pharmaceuticals, and are cosmetic products with bioactive ingredients that are validated by the science community. According to The Company’s... Read more
Pacla Medical Ltd is a health care device company developing a new generation robotic physiotherapy device (‘Robo-Physio’) to improve the symptoms of Multiple Sclerosis (MS), chronic back pain and other conditions. Current interventions for MS and back pain offer limited clinical benefits, with... Read more
The Company’s primary intention is the discovery of drugs that can prevent or inhibit the progression of Parkinson’s disease (‘PD’), for which there is currently no cure. Parkure’s primary goal is to discover and co-develop drugs that stop the disease progression; the Company will also exploit... Read more
PeptiGelDesign Limited provides formulated ready-to-use and easy-to-handle hydrogels for culture dishes, multi-well plates, or cell culture inserts, used in research laboratories. PeptigelDesign believe the research services market is large and growing, estimating it to be worth c.$20bn on a... Read more
Pronec Ltd seeks to develop a new class of cancer therapy that causes tumours to simply die, using proprietary peptides. The Company has identified a lead candidate molecule that causes necrosis of a wide range of tumour cell lines in culture, but does not affect normal cell lines. Cancer cell... Read more
The Company was established in 2016 to exploit opportunities within the pharmaceutical sector, specifically delivering a solution to reduce manufacturing costs and increase output. To do so, the Company has established a novel technological process called ‘zero step purification’. The... Read more
Established in February 2017, the Company intends to address the unmet needs of early-stage life science companies, by automating their R&D tax claims process, as well as provide life-sciences management and equipment location services. RDvault seeks to digitise a very manual, timely and... Read more
Founded in 2017 by consultant cardiologists, Dr Jonas EichhÖfer and Dr Ahmed Farag, the Company seeks to develop a novel app-based cardiac rehabilitation platform, called ‘RehApp’, specifically designed to support both cardiac doctors, rehabilitation nurses, and patients recovering from a recent... Read more
Renephra Ltd is a UK based medical device development company that has developed and patented a disruptive technology that addresses the significant ongoing medical problems associated with treatment resistance of fluid overload within the body. Health issues often associated with fluid... Read more
The Company is developing a novel catheter system that enables patients to receive haemodialysis (‘HD’) in an improved manner. Currently, patients receiving HD must undergo a surgical procedure to create a surgical connection between an artery and a vein, the vein then acts as a ‘vascular access... Read more
T-EDTA Limited was established to develop anti-biofilm technologies and infection control products. Anti-biofilm is used in advanced wound care products using the anti-biofilm agents tri sodium/tetra sodium EDTA (‘t-EDTA’). A biofilm is a group of microorganisms in which cells stick to... Read more
Tookie Ltd has developed a portfolio of innovative products addressing the unmet needs of patients who have genuine medical problems surrounding the security of central venous catheters (‘CVC’). The catheters are put in place to allow long-term medicine treatment for pain, infection, or... Read more
Transcriptogen Ltd has developed a new approach to the treatment of cancer. The Company has developed a lead molecule, TSG1301, which has been shown to be highly effective at treating Breast and Pancreatic Cancer in human tumours that have been grafted onto mice. In addition, it appears to... Read more
Viscgo was founded in August 2015 by Dr Elizabeth Boaden and Mr Steven Bookbinder to solve the medical need for consistently and accurately measuring the viscosity of differing drinks and textured modified foods for those people being treated with differing levels of dysphagia (i.e. swallowing... Read more